Education
About Us
Working with TipRanks
Follow Us
Tiziana Life Sciences (US) (TLSA)
:TLSA
Total Valuation
Tiziana Life Sciences has a market cap or net worth of $180.65M. The enterprise value is ―.
Market Cap$180.65M
Enterprise Value―
Share Statistics
Tiziana Life Sciences has 118,851,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding118,851,950
Owned by Insiders39.00%
Owned by Institutions2.74%
Financial Efficiency
Tiziana Life Sciences’s return on equity (ROE) is -3.01 and return on invested capital (ROIC) is -269.73%.
Return on Equity (ROE)-3.01
Return on Assets (ROA)-1.05
Return on Invested Capital (ROIC)-269.73%
Return on Capital Employed (ROCE)-4.01
Revenue Per Employee0.00
Profits Per Employee-1.05M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tiziana Life Sciences is ―. Tiziana Life Sciences’s PEG ratio is 0.09.
PE Ratio―
PS Ratio0.00
PB Ratio9.43
Price to Fair Value9.43
Price to FCF-30.08
Price to Operating Cash Flow-9.43
PEG Ratio0.09
Income Statement
In the last 12 months, Tiziana Life Sciences had revenue of 0.00 and earned -11.86M in profits. Earnings per share was -0.22.
Revenue0.00
Gross Profit0.00
Operating Income-15.79M
Pretax Income-16.75M
Net Income-11.86M
EBITDA-16.62M
Earnings Per Share (EPS)-0.22
Cash Flow
In the last 12 months, operating cash flow was -8.36M and capital expenditures -9.99K, giving a free cash flow of -8.37M billion.
Operating Cash Flow-8.36M
Free Cash Flow-8.37M
Free Cash Flow per Share-0.07
Dividends & Yields
Tiziana Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.10
52-Week Price Change123.53%
50-Day Moving Average1.80
200-Day Moving Average1.64
Relative Strength Index (RSI)39.88
Average Volume (3m)336.65K
Important Dates
Tiziana Life Sciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Tiziana Life Sciences as a current ratio of 1.02, with Debt / Equity ratio of 1.21%
Current Ratio1.02
Quick Ratio1.02
Debt to Market Cap<0.01
Net Debt to EBITDA0.22
Interest Coverage Ratio-2.63K
Taxes
In the past 12 months, Tiziana Life Sciences has paid -4.88M in taxes.
Income Tax-4.88M
Effective Tax Rate0.29
Enterprise Valuation
Tiziana Life Sciences EV to EBITDA ratio is -2.02, with an EV/FCF ratio of -27.15.
EV to Sales0.00
EV to EBITDA-2.02
EV to Free Cash Flow-27.15
EV to Operating Cash Flow-27.48
Balance Sheet
Tiziana Life Sciences has $7.25M in cash and marketable securities with $107.00K in debt, giving a net cash position of $7.14M billion.
Cash & Marketable Securities$7.25M
Total Debt$107.00K
Net Cash$7.14M
Net Cash Per Share$0.06
Tangible Book Value Per Share$0.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tiziana Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―